Ingevity VP receives 2,063-share equity award
Cotterman Ryan Joseph reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Cotterman Ryan Joseph reported acquisition or exercise transactions in this Form 4 filing.
Ingevity Corp reported that VP and Chief Accounting Officer Ryan Joseph Cotterman received an equity grant of 2,063 shares of common stock as a compensation award. The grant represents restricted stock units under the Ingevity Corporation 2025 Omnibus Incentive Plan, issued at no cash cost to him.
These restricted stock units will vest in three equal installments on June 22, 2027, 2028, and 2029, tying part of his compensation to future service and company performance. Following this award, Cotterman directly holds 2,063 shares linked to this grant.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 2,063 | $0.00 | $0.00 |
Footnotes (1)
- F1. Grant of restricted stock units pursuant to the Ingevity Corporation 2025 Omnibus Incentive Plan, as amended, which will vest in three equal installments on June 22, 2027, 2028, and 2029.
Key Figures
Key Terms
restricted stock units financial
Omnibus Incentive Plan financial
Form 4 regulatory
Chief Accounting Officer financial
non-derivative financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Ingevity (NGVT) report for Ryan Joseph Cotterman?
What is the vesting schedule for the 2,063 restricted stock units at Ingevity (NGVT)?
AI-generated analysis. How Rhea-AI works. Not financial advice.